Nutrition

Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting

Medical Care Technologies Inc. (OTC PINK:MDCE) Expands Development of Consumer-Grade AI Pre-Health Screening Tools Focused on Early Detection

MESA, ARIZONA / ACCESS Newswire / December 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that the...

Functional Brands Inc. Announces P2i(TM) by Kirkman(R) as the World’s First Prenatal Supplement to Fully Align with FIGO’s Transparency Standards – and the First to Comply with California’s New SB 646 QR-Code Disclosure Law

error: Content is protected !!